Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial

Objectives: The high prevalence of arterial hypertension in primary hyperparathyroidism (pHPT) is largely unexplained. Apart from parathyroid hormone (PTH), the mineral hormones fibroblast growth factor (FGF)-23 and aldosterone-to-renin ratio (ARR) are upregulated in pHPT. We aimed to determine whet...

Full description

Saved in:
Bibliographic Details
Main Authors: Verheyen, Nicolas (Author) , März, Winfried (Author)
Format: Article (Journal)
Language:English
Published: September 1, 2016
In: Journal of hypertension
Year: 2016, Volume: 34, Issue: 9, Pages: 1778-1786
ISSN:1473-5598
DOI:10.1097/HJH.0000000000001004
Online Access:Verlag, Volltext: http://dx.doi.org/10.1097/HJH.0000000000001004
Verlag, Volltext: http://journals.lww.com/jhypertension/fulltext/2016/09000/Parathyroid_hormone,_aldosterone_to_renin_ratio.15.aspx
Get full text
Author Notes:Nicolas Verheyen, Astrid Fahrleitner-Pammer, Burkert Pieske, Andreas Meinitzer, Evgeny Belyavskiy, Julia Wetzel, Martin Gaksch, Martin R. Grübler, Cristiana Catena, Leonardo A. Sechi, Adriana J. Van Ballegooijen, Vincent M. Brandenburg, Hubert Scharnagl, Sabine Perl, Helmut Brussee, Winfried März, Stefan Pilz, and Andreas Tomaschitz

MARC

LEADER 00000caa a2200000 c 4500
001 1586420836
003 DE-627
005 20240316100551.0
007 cr uuu---uuuuu
008 190121s2016 xx |||||o 00| ||eng c
024 7 |a 10.1097/HJH.0000000000001004  |2 doi 
035 |a (DE-627)1586420836 
035 |a (DE-576)516420836 
035 |a (DE-599)BSZ516420836 
035 |a (OCoLC)1341033730 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Verheyen, Nicolas  |e VerfasserIn  |0 (DE-588)1160970009  |0 (DE-627)1024362299  |0 (DE-576)506293181  |4 aut 
245 1 0 |a Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism  |b the eplerenone in primary hyperparathyroidism trial  |c Nicolas Verheyen, Astrid Fahrleitner-Pammer, Burkert Pieske, Andreas Meinitzer, Evgeny Belyavskiy, Julia Wetzel, Martin Gaksch, Martin R. Grübler, Cristiana Catena, Leonardo A. Sechi, Adriana J. Van Ballegooijen, Vincent M. Brandenburg, Hubert Scharnagl, Sabine Perl, Helmut Brussee, Winfried März, Stefan Pilz, and Andreas Tomaschitz 
264 1 |c September 1, 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.09.2019 
520 |a Objectives: The high prevalence of arterial hypertension in primary hyperparathyroidism (pHPT) is largely unexplained. Apart from parathyroid hormone (PTH), the mineral hormones fibroblast growth factor (FGF)-23 and aldosterone-to-renin ratio (ARR) are upregulated in pHPT. We aimed to determine whether nocturnal blood pressure (BP) is related with PTH, FGF-23 or ARR in a relatively large sample of pHPT patients. Methods: Cross-sectional data of the single-center “Eplerenone in Primary Hyperparathyroidism” trial were used. All patients with a biochemical diagnosis of pHPT who had both available 24-h ambulatory BP monitoring and valid laboratory data were included. Results: Full data were available in 136 patients (mean age 67 ± 10 years, 78% women). Median PTH was 99 (interquartile range: 82-124) pg/ml and mean calcium was 2.63 ± 0.15 mmol/l. ARR, but not PTH or FGF-23, was significantly and directly related with nocturnal SBP (Pearson's r = 0.241, P < 0.01) and DBP (r = 0.328, P < 0.01). In multivariate regression analyses, with adjustment for age, sex, PTH, FGF-23, traditional cardiovascular risk factors, antihypertensive medication and parameters of calcium metabolism ARR remained significantly and directly related with nocturnal BP (SBP: adjusted β-coefficient = 0.289, P < 0.01; DBP: β = 0.399, P < 0.01). The relationship between ARR and nocturnal SBP was exclusively present in patients with PTH levels above the median of 99 pg/ml. Conclusion: ARR, but not FGF-23 or PTH, was independently and directly related with nocturnal BP parameters in patients with pHPT, and this relationship was dependent on pHPT disease severity. Inappropriately, elevated aldosterone may partially explain the high prevalence of arterial hypertension in pHPT. 
700 1 |a März, Winfried  |d 1958-  |e VerfasserIn  |0 (DE-588)1027603599  |0 (DE-627)729463605  |0 (DE-576)373454635  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hypertension  |d London : Lippincott, Williams & Wilkins, 1983  |g 34(2016), 9, Seite 1778-1786  |h Online-Ressource  |w (DE-627)320581373  |w (DE-600)2017684-3  |w (DE-576)091014018  |x 1473-5598  |7 nnas  |a Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism the eplerenone in primary hyperparathyroidism trial 
773 1 8 |g volume:34  |g year:2016  |g number:9  |g pages:1778-1786  |g extent:9  |a Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism the eplerenone in primary hyperparathyroidism trial 
856 4 0 |u http://dx.doi.org/10.1097/HJH.0000000000001004  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://journals.lww.com/jhypertension/fulltext/2016/09000/Parathyroid_hormone,_aldosterone_to_renin_ratio.15.aspx  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190121 
993 |a Article 
994 |a 2016 
998 |g 1027603599  |a März, Winfried  |m 1027603599:März, Winfried  |d 60000  |d 61400  |e 60000PM1027603599  |e 61400PM1027603599  |k 0/60000/  |k 1/60000/61400/  |p 16 
999 |a KXP-PPN1586420836  |e 304612760X 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"September 1, 2016","dateIssuedKey":"2016"}],"note":["Gesehen am 21.09.2019"],"recId":"1586420836","name":{"displayForm":["Nicolas Verheyen, Astrid Fahrleitner-Pammer, Burkert Pieske, Andreas Meinitzer, Evgeny Belyavskiy, Julia Wetzel, Martin Gaksch, Martin R. Grübler, Cristiana Catena, Leonardo A. Sechi, Adriana J. Van Ballegooijen, Vincent M. Brandenburg, Hubert Scharnagl, Sabine Perl, Helmut Brussee, Winfried März, Stefan Pilz, and Andreas Tomaschitz"]},"relHost":[{"id":{"issn":["1473-5598"],"zdb":["2017684-3"],"eki":["320581373"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"volume":"34","year":"2016","extent":"9","issue":"9","pages":"1778-1786","text":"34(2016), 9, Seite 1778-1786"},"pubHistory":["1.1983 -"],"origin":[{"dateIssuedKey":"1983","publisherPlace":"London","dateIssuedDisp":"1983-","publisher":"Lippincott, Williams & Wilkins"}],"recId":"320581373","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of hypertension","subtitle":"official journal of International Society of Hypertension, European Society of Hypertension","title":"Journal of hypertension"}],"language":["eng"],"disp":"Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism the eplerenone in primary hyperparathyroidism trialJournal of hypertension","note":["Gesehen am 27.11.20","Ungezählte Beil.: Suppl"]}],"title":[{"subtitle":"the eplerenone in primary hyperparathyroidism trial","title":"Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism","title_sort":"Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism"}],"id":{"eki":["1586420836"],"doi":["10.1097/HJH.0000000000001004"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"9 S."}],"person":[{"given":"Nicolas","family":"Verheyen","role":"aut","display":"Verheyen, Nicolas"},{"family":"März","given":"Winfried","display":"März, Winfried","role":"aut"}],"language":["eng"]} 
SRT |a VERHEYENNIPARATHYROI1201